Malnutrition Screening Study
LEVEL-UP Turkish Adult Outpatient Screening Study
1 other identifier
observational
7,500
1 country
1
Brief Summary
This is a non-interventional, cross-sectional, non-randomized, observational study to screen for the risk of malnutrition and sarcopenia in outpatients aged 18 and over who attend hospital clinics for any reason in Turkey.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2025
CompletedFirst Posted
Study publicly available on registry
December 1, 2025
CompletedStudy Start
First participant enrolled
January 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
January 29, 2026
January 1, 2026
6 months
November 21, 2025
January 28, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Malnutrition Risk
Measured via R-MAPP Screening Questionnaire completed by participant interview.
Screening Study Day 1
Sarcopenia Risk
Measured via R-MAPP Screening Questionnaire completed by participant interview.
Screening Study Day 1
Secondary Outcomes (6)
Body Mass Index (BMI)
Screening Study Day 1
Calf Circumference
Screening Study Day 1
Hand Grip Strength
Screening Study Day 1
Biochemical Parameters
Screening Study Day 1
Health Care Utilization
Screening Study Day 1
- +1 more secondary outcomes
Study Arms (1)
Hospital Clinics
Oncology, Neurology and Geriatric
Eligibility Criteria
Participants attending medical and radiation oncology, neurology, and geriatrics outpatient hospital clinics in Turkey
You may qualify if:
- Participant has voluntarily signed and dated an informed consent form (ICF), approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), and provided other applicable privacy regulation authorization (if applicable) prior to any participation in the study.
- Participant is ≥ 18 years of age who attend hospital clinics (medical and radiation oncology, neurology, and geriatrics clinics) as an outpatient for any reason.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbott Nutritionlead
Study Sites (1)
Necmettin Erbakan University Faculty of Medicine General Surgery
Meram, Konya, 42090, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Aysugul Alptekin, MD
Abbott Nutrition
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2025
First Posted
December 1, 2025
Study Start
January 12, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
January 29, 2026
Record last verified: 2026-01